These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36732416)

  • 1. Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice.
    Liu C; Song Z; Li Z; Boon MR; Schönke M; Rensen PCN; Wang Y
    Int J Obes (Lond); 2023 Mar; 47(3):236-243. PubMed ID: 36732416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
    Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
    Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
    Hoeke G; Wang Y; van Dam AD; Mol IM; Gart E; Klop HG; van den Berg SM; Pieterman EH; Princen HMG; Groen AK; Rensen PCN; Berbée JFP; Boon MR
    Atherosclerosis; 2017 Dec; 267():116-126. PubMed ID: 29121499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirabegron-induced brown fat activation does not exacerbate atherosclerosis in mice with a functional hepatic ApoE-LDLR pathway.
    Ying Z; van Eenige R; Beerepoot R; Boon MR; Kloosterhuis NJ; van de Sluis B; Bartelt A; Rensen PCN; Kooijman S
    Pharmacol Res; 2023 Jan; 187():106634. PubMed ID: 36574856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of brown fat activation on top of PCSK9 inhibition with alirocumab on dyslipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice.
    Zhou E; Li Z; Nakashima H; Choukoud A; Kooijman S; Berbée JFP; Rensen PCN; Wang Y
    Pharmacol Res; 2021 May; 167():105524. PubMed ID: 33667684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice.
    Ying Z; van Eenige R; Ge X; van Marwijk C; Lambooij JM; Guigas B; Giera M; de Boer JF; Coskun T; Qu H; Wang Y; Boon MR; Rensen PCN; Kooijman S
    EBioMedicine; 2023 Jul; 93():104684. PubMed ID: 37379656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.
    Bijland S; van den Berg SA; Voshol PJ; van den Hoek AM; Princen HM; Havekes LM; Rensen PC; Willems van Dijk K
    J Lipid Res; 2010 Jan; 51(1):97-102. PubMed ID: 19564641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
    Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding.
    Paalvast Y; Zhou E; Rozendaal YJW; Wang Y; Gerding A; van Dijk TH; de Boer JF; Rensen PCN; van Dijk KW; Kuivenhoven JA; Bakker BM; van Riel NAW; Groen AK
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development.
    Zhou E; Hoeke G; Li Z; Eibergen AC; Schonk AW; Koehorst M; Boverhof R; Havinga R; Kuipers F; Coskun T; Boon MR; Groen AK; Rensen PCN; Berbée JFP; Wang Y
    Cardiovasc Res; 2020 Aug; 116(10):1710-1720. PubMed ID: 31589318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice.
    Pouwer MG; Pieterman EJ; Chang SC; Olsen GW; Caspers MPM; Verschuren L; Jukema JW; Princen HMG
    Toxicol Sci; 2019 Apr; 168(2):519-534. PubMed ID: 30657992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice.
    van Eenige R; Ying Z; Tambyrajah L; Pronk ACM; Blomberg N; Giera M; Wang Y; Coskun T; van der Stelt M; Rensen PCN; Kooijman S
    J Lipid Res; 2021; 62():100070. PubMed ID: 33766515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.
    Berbée JF; Boon MR; Khedoe PP; Bartelt A; Schlein C; Worthmann A; Kooijman S; Hoeke G; Mol IM; John C; Jung C; Vazirpanah N; Brouwers LP; Gordts PL; Esko JD; Hiemstra PS; Havekes LM; Scheja L; Heeren J; Rensen PC
    Nat Commun; 2015 Mar; 6():6356. PubMed ID: 25754609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
    van Eenige R; Ying Z; Tramper N; Wiebing V; Siraj Z; de Boer JF; Lambooij JM; Guigas B; Qu H; Coskun T; Boon MR; Rensen PCN; Kooijman S
    Atherosclerosis; 2023 May; 372():19-31. PubMed ID: 37015151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.
    Liu C; Li Z; Song Z; Fan X; Shao H; Schönke M; Boon MR; Rensen PCN; Wang Y
    Atherosclerosis; 2022 Dec; 362():47-55. PubMed ID: 36347649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging attenuates diurnal lipid uptake by brown adipose tissue.
    In Het Panhuis W; Schönke M; Siebeler R; Afkir S; Baelde R; Pronk ACM; Streefland TCM; Sips HCM; Lalai RA; Rensen PCN; Kooijman S
    Aging (Albany NY); 2022 Oct; 14(19):7734-7751. PubMed ID: 36202134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP Mice.
    Zhou E; Li Z; Nakashima H; Liu C; Ying Z; Foks AC; Berbée JFP; van Dijk KW; Rensen PCN; Wang Y
    Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1474-1486. PubMed ID: 33567866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia.
    Berbée JFP; Mol IM; Milne GL; Pollock E; Hoeke G; Lütjohann D; Monaco C; Rensen PCN; van der Ploeg LHT; Shchepinov MS
    Atherosclerosis; 2017 Sep; 264():100-107. PubMed ID: 28655430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice.
    Li Z; Wang Y; van der Sluis RJ; van der Hoorn JW; Princen HM; Van Eck M; Van Berkel TJ; Rensen PC; Hoekstra M
    Biochem Pharmacol; 2012 Sep; 84(6):821-9. PubMed ID: 22750059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.